4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine has been researched along with 5-iodotubercidin in 1 studies
Studies (4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine) | Trials (4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine) | Recent Studies (post-2010) (4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine) | Studies (5-iodotubercidin) | Trials (5-iodotubercidin) | Recent Studies (post-2010) (5-iodotubercidin) |
---|---|---|---|---|---|
6 | 0 | 0 | 140 | 0 | 42 |
Protein | Taxonomy | 4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine (IC50) | 5-iodotubercidin (IC50) |
---|---|---|---|
Chain A, Mitogen-activated protein kinase 3 | Homo sapiens (human) | 0.9 | |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | 1.2 | |
Adenosine kinase | Homo sapiens (human) | 0.1583 | |
Adenosine kinase | Mycobacterium tuberculosis H37Rv | 1.2 | |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.071 | |
Histone-lysine N-methyltransferase, H3 lysine-79 specific | Homo sapiens (human) | 7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drach, JC; Nassiri, MR; Pudlo, JS; Saxena, NK; Townsend, LB; Turk, SR | 1 |
1 other study(ies) available for 4-amino-5-bromo-7-(2-hydroxyethoxymethyl)pyrrolo(2,3-d)pyrimidine and 5-iodotubercidin
Article | Year |
---|---|
Synthesis and antiviral activity of certain 4- and 4,5-disubstituted 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidines.
Topics: Acyclovir; Aminoglycosides; Anti-Bacterial Agents; Cell Survival; Chemical Phenomena; Chemistry; Cytomegalovirus; Humans; Tubercidin | 1988 |